Edwards Lifesciences Corp. (EW) reported first quarter EPS of $1.24 after the bell Tuesday, up from $0.55 a year ago. The consensus estimate was for EPS of $0.76. Second quarter EPS is expected to be between $0.75 and $0.79. The consensus estimate is for EPS of $0.81. The stock is now down 12.16 on 521K shares.
Edwards Lifesciences reversed its early gains in the early portion of the afternoon and ended the session with a loss of 0.82 at $82.81. The stock finished at the lower end of a 2-week range.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.